Consider Using Subcutaneous Methotrexate More for Rheumatoid Arthritis

April 2018

You'll see more methotrexate options for rheumatoid arthritis.

Oral methotrexate is still first-line for rheumatoid arthritis. But some patients may find it hard to tolerate...making it tempting to go to other DMARDs (sulfasalazine, etc) or biologics (Humira, etc) too soon.

Evidence suggests SUBCUTANEOUS methotrexate may have fewer GI side effects than oral and be more effective because it's better absorbed...especially at doses of 15 mg or more per week.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Diabetes Don't Think of A1C Goals as "One-Size-Fits-All"
Vaccines Resolve Common Questions About Shingrix Administration
Cardiology Manage New Warnings About Clarithromycin and Cardiovascular Risk
Infectious Diseases Lean Toward Oral Vancomycin for Initial Treatment of C. diff Diarrhea
Fentanyl Patches Follow Safeguards When Prescribing Fentanyl Patches
Rheumatoid Arthritis Consider Using Subcutaneous Methotrexate More for Rheumatoid Arthritis
Cannabinoids Know How the Rx Cannabinoids Compare
Men's Health Consider if Meds or Supplements May Be Contributing to Male Infertility
Asthma Close the Gap in Asthma Care in Kids
Aspirin Be Prepared With the Latest Answers About Aspirin
Insulin Watch for New "Follow-On" Mealtime Insulin Admelog (Lispro)

Consider Using Subcutaneous Methotrexate More for Rheumatoid Arthritis

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents